Scholarlink

<p>Medicinal plants remain a valuable source of structurally diverse natural products with therapeutic potential. <i>Tapinanthus globiferus</i> (Loranthaceae) is widely used for the treatment of cancer-related conditions, yet its chemical and pharmacological basis remains poorly defined. In this study, phytochemical profiling, cytotoxicity testing, and computational analyses were employed to characterize the bioactive potential of <i>T. globiferus</i> leaves. The leaves were subjected to extraction using 70% methanol and subsequently fractionated using butanol. The butanol fraction demonstrated notable cytotoxic activity against HT29 colon cancer cells, consistent with morphological evidence of apoptosis. High-performance liquid chromatography with diode array detection (HPLC–DAD) revealed the presence of abundant phenolic and flavonoid constituents, including kaempferol and quercetin derivatives, rutin, isoquercetin, catechin, and protocatechuic acid, which were identified as candidate marker compounds. To explore mechanisms, major identified compounds were docked in silico to VEGF-A and the anti-apoptotic protein BCL-2. Rutin, trifolin (a kaempferol glycoside), and epigallocatechin exhibited the strongest binding (e.g. rutin: −&#xa0;8.85&#xa0;kcal/mol to VEGF-A), surpassing the reference inhibitor Pazopanib (−&#xa0;3.56&#xa0;kcal/mol) with multiple stabilizing interactions with these proteins, suggesting potential to interfere with tumor angiogenesis and cell survival pathways. Collectively, these findings provide a scientific basis for the traditional use of <i>T. globiferus</i> and support its fraction as promising sources of multi-targeted anticancer agents. The identification of bioactive compounds further establishes a foundation for bioassay-guided isolation, mechanistic validation, and future drug development.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Identification of anticancer compounds from Tapinanthus globiferus: integrating in vitro and in silico approaches

  • 期刊论文

  • 发表日期：

    2026年2月26日

查看全文
  • Jane-Rose I. Oche,
  • Oluwabukola M. Farodoye,
  • Camila Sant’Anna Monteiro,
  • Jonathan D. Dabak,
  • Titilayo O. Johnson

摘要

Medicinal plants remain a valuable source of structurally diverse natural products with therapeutic potential. Tapinanthus globiferus (Loranthaceae) is widely used for the treatment of cancer-related conditions, yet its chemical and pharmacological basis remains poorly defined. In this study, phytochemical profiling, cytotoxicity testing, and computational analyses were employed to characterize the bioactive potential of T. globiferus leaves. The leaves were subjected to extraction using 70% methanol and subsequently fractionated using butanol. The butanol fraction demonstrated notable cytotoxic activity against HT29 colon cancer cells, consistent with morphological evidence of apoptosis. High-performance liquid chromatography with diode array detection (HPLC–DAD) revealed the presence of abundant phenolic and flavonoid constituents, including kaempferol and quercetin derivatives, rutin, isoquercetin, catechin, and protocatechuic acid, which were identified as candidate marker compounds. To explore mechanisms, major identified compounds were docked in silico to VEGF-A and the anti-apoptotic protein BCL-2. Rutin, trifolin (a kaempferol glycoside), and epigallocatechin exhibited the strongest binding (e.g. rutin: − 8.85 kcal/mol to VEGF-A), surpassing the reference inhibitor Pazopanib (− 3.56 kcal/mol) with multiple stabilizing interactions with these proteins, suggesting potential to interfere with tumor angiogenesis and cell survival pathways. Collectively, these findings provide a scientific basis for the traditional use of T. globiferus and support its fraction as promising sources of multi-targeted anticancer agents. The identification of bioactive compounds further establishes a foundation for bioassay-guided isolation, mechanistic validation, and future drug development.